Last Updated: 09/18/2022
Methylmalonic acidemia is a disorder in which the body cannot break down certain proteins and fats. The result is a buildup of a substance called methylmalonic acid in the blood. This condition is passed down through families.
It is one of several conditions called an "inborn error of metabolism."
MediFind is the industry authority on identifying the leading medical experts and latest research in order to help patients facing complex health challenges, including Optic Nerve Atrophy, make better health decisions. Leveraging our expertise in natural language processing and machine learning across thousands of diseases, we uncover physicians who are leading authorities on Optic Nerve Atrophy. MediFind identifies these experts using proprietary world-class models that assess over 2.5 million global doctors based on a range of variables, including research leadership, patient volume, peer standing, and connectedness to other experts. Learn more about our methodology by exploring how MediFind works.